Six months after the passage of the Crimes Legislation Amendment (Combatting Foreign Bribery) Act 2024, the Australian government has published important guidance on the “adequate procedures” companies should have in place in...more
The Singapore government has refused to renew the visa of the U.S.-born chief executive of a shipping company after the company was designated by the U.S. Treasury for breaching Russian sanctions. Separately, a Singapore...more
A public consultation on a new regulatory framework for single family offices in Singapore closes on 30 September 2023. The proposed new framework will introduce qualifying criteria for class exemption from licensing under...more
2023 is proving an eventful year for Singapore anti-money laundering legislation. In the first half of this year, the Ministry of Home Affairs (MHA) proposed two bills, intended to strengthen the country’s legal framework...more
2022 has been a year which has seen significant developments in court-led corporate rescue and insolvency law reform in Hong Kong. In light of the lingering COVID19 pandemic, it was all the more important that the Hong Kong...more
Since 1 October 2022, the Singapore International Commercial Court now has jurisdiction to hear cross-border restructuring and insolvency matters. In addition, foreign lawyers may be appointed to make submissions in...more
The sanctions were first announced in parliament on 28 February 2022, and the specifics were released on 5 March 2022....more
Singapore is getting serious about becoming the region’s international insolvency hub. In this inaugural podcast from the International Insolvency Institute, Hon. Kevin Carey (Ret.) of Hogan Lovells discusses Hon....more
After a summer hiatus, we return with a warning of imminent AML controls; a trend we witness across the region. On 1 October 2021, the Monetary Authority of Singapore (“MAS”) published a Consultation Paper on the FI-FI...more
In 2020, heightened demand for health care resulted in an influx of therapeutic goods being included on the Australian Register of Therapeutic Goods (ARTG). A large portion of these goods are manufactured in China however,...more
3/18/2021
/ Australia ,
China ,
Coronavirus/COVID-19 ,
Infectious Diseases ,
Life Sciences ,
Manufacturers ,
Masks ,
Medical Devices ,
Personal Protective Equipment ,
Pharmaceutical Industry ,
Public Health ,
Regulatory Requirements ,
Supply and Demand ,
Supply Chain